KR900006347A - 살균성 플루오로퀴놀로닐 세펨 - Google Patents
살균성 플루오로퀴놀로닐 세펨 Download PDFInfo
- Publication number
- KR900006347A KR900006347A KR1019890015236A KR890015236A KR900006347A KR 900006347 A KR900006347 A KR 900006347A KR 1019890015236 A KR1019890015236 A KR 1019890015236A KR 890015236 A KR890015236 A KR 890015236A KR 900006347 A KR900006347 A KR 900006347A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- alkyl
- heterocyclic ring
- alkenyl
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (7)
- 하기 일반식(I)의 화합물 및 이의 약제학적으로 허용되는 염, 생가수분해성 에스테르 및 수화물.상기식에서, R1은 수소, 할로겐, 알킬, 알케닐, 헤테로알킬, 카보사이클릭환, 헤테로사이클릭환, R10a-C-, R10aCH=N-, (R10)(R11)N-, R12-C(=CHR15)-C(=O)NH-, R12-C(=NO-R14)-C(=O)NH-, 또는 R13-(CH2)m-C(=O)NH-이며, 바람직하게는 알킬, 알케닐, R12-C(=NO-R14)-C(=O)NH-, 또는 R13-(CH2)m-C(=O)NH-이고, m은 0 내지 9, 바람직하게는 0 내지 3의 정수이며, R10및 R11은 각각 R10a이거나, R10및 R11이 함께는 이들이 결합된 질소를 함유한 헤테로사이클릭환을 포함하고, R10a는 수소, 알킬, 알케닐, 카보사이클릭환, 또는 헤테로사이클릭환 치환체이며, R12는 수소, 알킬, 알케닐, 헤테로알킬, 헤테로알케닐, 카보사이클릭환, 또는 헤테로사이클릭환이며, 바람직하게는 알킬, 카보사이클릭환 또는 헤테로사이클릭환이고, R13은 R12, -Z1또는 -CH(Z2)(R12)이며, R14는 R12아릴알킬, 헤테로아릴알킬, -C(=R17)(R18)COOH, -C(=O)O-R12, 또는 -C(=O)NH-R12이고, 바람직하게는 R12또는 -C(R17)(R18)COOH이며, R17및 R18은 각각 R12이거나, R17및 R18이 함께는 이들이 결합된 탄소원자를 함유한 카보사이클릭환 또는 헤테로사이클릭환을 포함하고, R15는 R14, 할로겐, -Z1, 또는 -CH(Z2)(R12)이며, 바람직하게는 R14또는 할로겐이고, Z1은 -C(=O)OR16, -C(=O)(R16), -N(R19)R16, -S(O)pR24, 또는 -OR24이며, Z2는 Z1, 또는 OH, -SH 또는 -SO3H이고, p는 0 내지 2의 정수이며, 바람직하게는 0이고, R19는 수소, 알킬, 알케닐, 헤테로알킬, 헤테로알케닐, 카보사이클릭환, 헤테로사이클릭환, -SO3H 또는 -C(=O)R20이거나, R13이 -CH(Z2)(R12)이고, Z2가 -N(R19)R16인 경우에 R19는 R16과 결합하여 헤테로사이클릭환을 형성하는 잔기를 포함할 수 있으며, R20은 R12, NH(R12), N(R12)(R21), O(R21), 또는 S(R21)이고, 바람직하게는 R12, NH(R12), 또는 N(R12)(R21)이며, R21은 알킬, 알케닐, 카보사이클릭환, 또는 헤테로사이클릭환이거나, R20이 N(R12)(R21)인 경우에 R21은 R12와 결합하여 헤테로사이클릭환을 형성하는 잔기일 수 있고, R16은 R24또는 수소이며, 바람직하게는 수소, 알킬, 카보사이클릭환 또는 헤테로사이클릭환이고, R24는 알킬, 알케닐, 아릴알킬, 헤테로알킬, 헤테로알케닐, 헤테로아릴알킬, 카보사이클릭환 또는 헤테로사이클릭환기어나, Z1이 N(R19)R16이고 R16이 R24인 경우에 R16및 R19는 함께 R19가 결합된 질소원자를 함유한 헤테로사이클릭환을 포함할 수 있으며, R2는 수소, 할로겐, 알콕시, 또는 R22(=O)NH-이고, 바람직하게는 수소 또는 알콕시이며, R22는 수소 또는 알킬이고, R3은 질소-함유 헤테로사이클릭환이며, C4는 수소, 하이드록시, 알콕시, 디트로, 시아노, 할로겐, 알킬 또는 N(R10)(R11)이다.
- 제1항에 있어서, R2가 수소 또는 알콕시인 화합물.
- 제1항에 있어서, R4가 수소 또는 할로이며, 바람직하게는 염소 또는 불소인 화합물.
- 제3항에 있어서, R3이 피페라진, 3-메틸피페라진, 3-아미노피롤리딘, 3-아미노메틸피롤리딘, N,N-디메틸이미노메틸피롤리딘, N-메틸이미노메틸피롤리딘, N-에틸아미노메틸피롤리딘, 피리딘, N-메틸피페라진, 또는 3,5-디메틸피페라진이며, 바람직하게는 피페라진인 화합물.
- 안전하고 유효한 양의 제1,2,3 또는 4항에 따른 화합물 및 약제학적으로 허용되는 담체를 함유함을 특징으로 하여, 인간 또는 다른 동물환자의 감연성 질환을 예방 또는 치료하기 위한 조성물.
- 제5항에 있어서, 비경구 투여에 적합한, 인간 또는 다른 동물환자의 감염성 질환을 예방 또는 치료하기 위한 조성물.
- 제5항에 있어서, 경구 투여에 적합한, 인간 또는 다른 동물환자의 감염성 질환을 예방 또는 치료하기 위한 조성물.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26194988A | 1988-10-24 | 1988-10-24 | |
US261,949 | 1988-10-24 | ||
US?261,949? | 1988-10-24 | ||
US41802589A | 1989-10-12 | 1989-10-12 | |
US?418,025? | 1989-10-12 | ||
US418,025 | 1989-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900006347A true KR900006347A (ko) | 1990-05-08 |
KR0139638B1 KR0139638B1 (ko) | 1998-06-01 |
Family
ID=26948930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019890015236A KR0139638B1 (ko) | 1988-10-24 | 1989-10-24 | 살균성 플루오로퀴놀닐 세펨 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0366640B1 (ko) |
JP (1) | JPH03503421A (ko) |
KR (1) | KR0139638B1 (ko) |
AT (1) | ATE176473T1 (ko) |
AU (1) | AU620651B2 (ko) |
CA (1) | CA2001204A1 (ko) |
DE (1) | DE68928925T2 (ko) |
DK (1) | DK527389A (ko) |
ES (1) | ES2129388T3 (ko) |
GR (1) | GR3030052T3 (ko) |
NZ (1) | NZ231113A (ko) |
PH (1) | PH26519A (ko) |
SG (1) | SG54293A1 (ko) |
WO (1) | WO1990004595A1 (ko) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5147871A (en) * | 1986-07-03 | 1992-09-15 | Hoffmann La-Roche, Inc. | Anti-bacterial cephalosporin compounds |
US5336768A (en) * | 1988-05-24 | 1994-08-09 | Hoffmann-La Roche Inc. | Antibacterial cephalosporin compounds |
CS273349B2 (en) * | 1988-03-31 | 1991-03-12 | Hoffmann La Roche | Method of cephalosporin's new derivatives production |
US5491139A (en) * | 1988-10-24 | 1996-02-13 | The Procter & Gamble Company | Antimicrobial quinolonyl lactams |
US5273973A (en) * | 1988-10-24 | 1993-12-28 | Norwich Eaton Pharmaceuticals, Inc. | Antimicrobial quinolonyl esters |
EP0366189A3 (en) * | 1988-10-24 | 1992-01-02 | Norwich Eaton Pharmaceuticals, Inc. | Novel antimicrobial lactam-quinolones |
CA2001203C (en) * | 1988-10-24 | 2001-02-13 | Thomas P. Demuth, Jr. | Novel antimicrobial dithiocarbamoyl quinolones |
US5180719A (en) * | 1988-10-24 | 1993-01-19 | Norwich Eaton Pharmaceuticals, Inc. | Antimicrobial quinolonyl lactam esters |
US5328908A (en) * | 1988-10-24 | 1994-07-12 | Procter & Gamble Pharmaceuticals, Inc. | Antimicrobial quinolone thioureas |
US5162523A (en) * | 1989-07-21 | 1992-11-10 | Hoffmann-La Roche Inc. | Cephalosporin antibacterial compounds |
US5159077A (en) * | 1989-07-21 | 1992-10-27 | Hoffmann-La Roche Inc. | Penam antibacterial compounds |
EP0525057B1 (en) * | 1990-04-18 | 2000-06-14 | Procter & Gamble Pharmaceuticals, Inc. | Antimicrobial quinolonyl lactams |
US5066800A (en) * | 1990-04-27 | 1991-11-19 | Hoffmann-La Roche Inc. | Qunoline intermediates useful therein for synthesizing antibacterial compounds |
DE69218445T2 (de) * | 1991-10-01 | 1997-08-07 | Procter & Gamble Pharma | Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen |
DE4234330A1 (de) * | 1992-10-12 | 1994-04-14 | Bayer Ag | Chinoloncarbonsäuren |
FR2873695A1 (fr) * | 2004-07-30 | 2006-02-03 | Palumed Sa | Molecules hybrides qa ou q est une aminoquinoleine et a est un antibiotique ou un inhibiteur de resistance), leur synthese et leurs utilisations en tant qu'agent antibacterien |
GB201818410D0 (en) * | 2018-11-12 | 2018-12-26 | Imperial Innovations Ltd | Compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS565484A (en) * | 1979-06-27 | 1981-01-20 | Dainippon Pharmaceut Co Ltd | Cephalosporin derivative and its salt |
JPS565485A (en) * | 1979-06-27 | 1981-01-20 | Dainippon Pharmaceut Co Ltd | Cephalosporin derivative and its salt |
ZA874696B (en) * | 1986-07-03 | 1988-01-04 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Acyl derivatives |
JP2676082B2 (ja) * | 1987-12-25 | 1997-11-12 | 住友化学工業株式会社 | ゴキブリ防除用マイクロカプセル剤 |
NZ227470A (en) * | 1987-12-28 | 1991-06-25 | Hoffmann La Roche | Acyl derivatives of substituted cephem compounds; pharmaceutical compositions and methods for preparation and treatment |
EP0366193A3 (en) * | 1988-10-24 | 1992-01-08 | Norwich Eaton Pharmaceuticals, Inc. | Novel antimicrobial quinolonyl lactams |
EP0366189A3 (en) * | 1988-10-24 | 1992-01-02 | Norwich Eaton Pharmaceuticals, Inc. | Novel antimicrobial lactam-quinolones |
CA2001203C (en) * | 1988-10-24 | 2001-02-13 | Thomas P. Demuth, Jr. | Novel antimicrobial dithiocarbamoyl quinolones |
-
1989
- 1989-10-20 EP EP89870151A patent/EP0366640B1/en not_active Expired - Lifetime
- 1989-10-20 DE DE68928925T patent/DE68928925T2/de not_active Expired - Fee Related
- 1989-10-20 AT AT89870151T patent/ATE176473T1/de not_active IP Right Cessation
- 1989-10-20 SG SG1996007907A patent/SG54293A1/en unknown
- 1989-10-20 ES ES89870151T patent/ES2129388T3/es not_active Expired - Lifetime
- 1989-10-23 CA CA002001204A patent/CA2001204A1/en not_active Abandoned
- 1989-10-24 PH PH39400A patent/PH26519A/en unknown
- 1989-10-24 KR KR1019890015236A patent/KR0139638B1/ko not_active IP Right Cessation
- 1989-10-24 AU AU43697/89A patent/AU620651B2/en not_active Ceased
- 1989-10-24 DK DK527389A patent/DK527389A/da not_active Application Discontinuation
- 1989-10-24 JP JP2501184A patent/JPH03503421A/ja active Pending
- 1989-10-24 NZ NZ231113A patent/NZ231113A/en unknown
- 1989-10-24 WO PCT/US1989/004768 patent/WO1990004595A1/en unknown
-
1999
- 1999-04-26 GR GR990401132T patent/GR3030052T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH03503421A (ja) | 1991-08-01 |
DK527389A (da) | 1990-04-25 |
CA2001204A1 (en) | 1990-04-24 |
AU620651B2 (en) | 1992-02-20 |
GR3030052T3 (en) | 1999-07-30 |
DE68928925D1 (de) | 1999-03-18 |
EP0366640B1 (en) | 1999-02-03 |
NZ231113A (en) | 1992-06-25 |
AU4369789A (en) | 1990-04-26 |
DK527389D0 (da) | 1989-10-24 |
EP0366640A3 (en) | 1992-01-02 |
PH26519A (en) | 1992-08-07 |
EP0366640A2 (en) | 1990-05-02 |
KR0139638B1 (ko) | 1998-06-01 |
ATE176473T1 (de) | 1999-02-15 |
SG54293A1 (en) | 1998-11-16 |
ES2129388T3 (es) | 1999-06-16 |
DE68928925T2 (de) | 1999-08-26 |
WO1990004595A1 (en) | 1990-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900006347A (ko) | 살균성 플루오로퀴놀로닐 세펨 | |
KR930701434A (ko) | 옥사졸리딘 디온 유도체 | |
NO931317L (no) | Et terapeutisk middel for parkinson's sykdom | |
KR960007592A (ko) | 신규한 피롤로카바졸 | |
KR930700514A (ko) | 항미생물성 퀴놀로닐 락탐 | |
KR890011596A (ko) | 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도 | |
KR930016402A (ko) | 항-hiv 활성을 갖는 이미다졸 유도체 | |
AU7379187A (en) | Substituted 2-thiazolyl-imidazo{1,2-a}pyrimidine derivatives | |
ZA889023B (en) | 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them | |
NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
KR920007995A (ko) | 벤즈아미드 유도체 | |
KR900016178A (ko) | 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물 | |
SE8304071L (sv) | Nya piperazinderivat | |
KR890008148A (ko) | 새로운 세파로스포린 화합물 및 항균제 | |
KR900009640A (ko) | 벤족 사제핀 유도체 | |
DE3866292D1 (de) | Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE49761T1 (de) | 8-thiotetrahydrochinoleinderivate und deren salze. | |
DE3889993D1 (de) | 2'-Deoxy-5-fluorouridin-Derivate. | |
DE68919869T2 (de) | Cephalosporinderivate. | |
HUP0000275A2 (hu) | Fenantridiniumszármazékok, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
ES2045514T3 (es) | Utilizacion de derivados del cromano para el tratamiento de los estados depresivos. | |
ES519530A0 (es) | Procedimiento para la preparacion de tienobenzodiazepinonas sustituidas. | |
ATE56442T1 (de) | 2,6-piperazin-dion-derivate, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
PT77466B (de) | Neue 4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxide verfahren zu ihrer herstellung ihre verwendung und diese verbindungen enthaltende arzneimittel | |
ATE28192T1 (de) | 4-alkylimidazol-derivate, ihre herstellung und verwendung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |